1. Home
  2. IQ vs AORT Comparison

IQ vs AORT Comparison

Compare IQ & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iQIYI Inc.

IQ

iQIYI Inc.

HOLD

Current Price

$2.02

Market Cap

2.4B

ML Signal

HOLD

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$45.16

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IQ
AORT
Founded
2009
1984
Country
China
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
2018
1993

Fundamental Metrics

Financial Performance
Metric
IQ
AORT
Price
$2.02
$45.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$2.87
$49.36
AVG Volume (30 Days)
10.1M
355.3K
Earning Date
11-18-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,808,085,043.00
$422,646,000.00
Revenue This Year
N/A
$15.97
Revenue Next Year
$2.72
$10.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.81
52 Week Low
$1.50
$21.97
52 Week High
$2.84
$48.04

Technical Indicators

Market Signals
Indicator
IQ
AORT
Relative Strength Index (RSI) 40.98 52.23
Support Level $1.97 $42.68
Resistance Level $2.08 $46.02
Average True Range (ATR) 0.07 1.35
MACD -0.00 -0.25
Stochastic Oscillator 20.00 56.87

Price Performance

Historical Comparison
IQ
AORT

About IQ iQIYI Inc.

Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: